Preparation and characterization of neurotoxic tau oligomers

C.A. Lasagna-Reeves, D.L. Castillo-Carranza, M.J. Guerrero-Muñoz, G.R. Jackson, R. Kayed

Research output: Contribution to journalArticlepeer-review

284 Citations (Scopus)


Tau aggregation is a pathological hallmark of Alzheimer's disease, Parkinson's disease, and many other neurodegenerative disorders known as tauopathies. Tau aggregates take on many forms, and their formation is a multistage process with intermediate stages. Recently, tau oligomers have emerged as the pathogenic species in tauopathies and a possible mediator of amyloid-β toxicity in Alzheimer's disease. Here, we use a novel, physiologically relevant method (oligomer cross-seeding) to prepare homogeneous populations of tau oligomers and characterize these oligomers in vitro. We show that both Aβ and α-synuclein oligomers induce tau aggregation and the formation of β-sheet-rich neurotoxic tau oligomers.

Original languageEnglish
Pages (from-to)10039-10041
Number of pages3
Issue number47
Publication statusPublished - 30 Nov 2010
Externally publishedYes

Bibliographical note

Copyright 2011 Elsevier B.V., All rights reserved.

All Science Journal Classification (ASJC) codes

  • Biochemistry


Dive into the research topics of 'Preparation and characterization of neurotoxic tau oligomers'. Together they form a unique fingerprint.

Cite this